Immunalysis develops, manufactures and markets immunoassay reagents for the screening of Drugs of Abuse and other small molecules in a variety of biological matrices. The company draws upon its expertise in organic chemistry, immunology, biochemistry, assay development and quality control, to supply immunoassay reagents and validated automation options. This combination provides a forensic toxicologist with powerful complete drug screening solutions to meet the challenges demanded by alternative matrices.
